7T-MRI scaning for Parkinson's (NCT06449404)
Detect early Parkinson brain changes
- Trial ID
- NCT06449404
- Official Title
- 7.0T Magnetic Resonance Imaging Study of Parkinson's Disease
- Goal
- Detect early Parkinson brain changes
- Status
- RECRUITING
- Sponsor
- Chinese PLA General Hospital
- Study Type
- OBSERVATIONAL
- Enrollment
- 200 participants
- Conditions
- Parkinson's Diseases, MRI
- Interventions
- 7T-MRI scaning
Summary For Families
The goal is to use ultra-high-field 7 Tesla MRI to get much clearer pictures of Parkinson's-related brain changes, for example finer detail in the substantia nigra and patterns of iron buildup that lower-field scans may miss. Participants get a non-invasive 7T MRI scan that maps brain structure and tissue properties, there is no experimental drug or device involved, and the scan does not change your usual Parkinson's medications. Adults aged 18 to 80 who have been diagnosed with Parkinson's by a movement disorders neurologist can join. People with other brain disorders, significant psychiatric or cognitive problems, or any contraindication to MRI are not eligible.
Locations
- Chinese PLA General Hospital, Beijing, Beijing, China, China
Frequently Asked Questions
- What is this trial testing?
- This trial is studying 7T-MRI scaning. The goal is to use ultra-high-field 7 Tesla MRI to get much clearer pictures of Parkinson's-related brain changes, for example finer detail in the substantia nigra and patterns of iron buildup that lower-field scans may miss. Participants get a non-invasive 7T MRI scan that maps brain structure and tissue properties, there is no experimental drug or device involved, and the scan does not change your usual Parkinson's medications. Adults aged 18 to 80 who have been diagnosed with Parkinson's by a movement disorders neurologist can join. People with other brain disorders, significant psychiatric or cognitive problems, or any contraindication to MRI are not eligible.
- Who can participate?
- Participants must be between 18 Years and 80 Years.
- Where is this trial located?
- This trial is recruiting at 1 location.
- Does it cost anything to join?
- You are never charged a fee to join a legitimate clinical trial, and the study treatment and study-specific tests are provided by the trial sponsor at no charge. In the US, routine care you would receive anyway can still be billed to you or your insurance; coverage rules differ by country, and trials in the UK and Canada usually run through public health systems. Travel, parking, and time are real costs, and some trials reimburse them while others do not. Before enrolling, ask the study coordinator to explain in writing what is and is not covered.
- How long does the trial last?
- This trial is estimated to last approximately 5 years and 4 months.
- Can I leave the trial if I change my mind?
- Yes. You can withdraw from any clinical trial at any time, for any reason, without affecting your standard medical care. Trials are voluntary by law. The team may ask if you are willing to do a brief exit visit so they can collect safety information, but you are not obligated.
- Can my spouse or care partner come with me to visits?
- In most cases yes, and it is often encouraged. Care partners can help with notes, questions, and getting home safely after a long visit. Some study assessments do need to happen one on one, but care partners are usually welcome for the rest of the appointment.
- Will I get a placebo in this trial?
- This is an observational study, so there is no placebo and no experimental treatment is assigned. Researchers observe and collect information while you continue your usual care.
- What procedures are involved in this trial?
- Based on the protocol, this trial involves: MRI scan (non-invasive). Confirm the full schedule with the study coordinator.